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doi:10.1Objectives: The purpose of this study was to determine whether acute renal injury develops more frequently in
women than in men after cardiac surgery and whether this complication is associated with operative mortality in
women.
Methods: Prospectively collected data were evaluated from 9461 patients undergoing coronary artery bypass
graft surgery, cardiac valve surgery, or both (3080 women) and not receiving preoperative dialysis. The glomer-
ular filtration rate was estimated by using the Modification of Diet in Renal Disease equations with the last plasma
creatinine level before surgical intervention (baseline) and the highest level of the first postoperative week. The
primary renal injury outcome was the composite end point of renal injury according to RIFLE criteria (estimated
glomerular filtration rate decrease>50% from baseline value) or failure.
Results: Thirty-day operative mortality and renal injury were more common in women than in men (5.9% vs
2.8%, P¼ .01; 5.1% vs 3.6%, P<.001, respectively). Nonetheless, patient sex was not independently associated
with risk for renal injury when the baseline estimated glomerular filtration rate was included in multivariate mod-
eling. Perioperative complications, intensive care unit length of stay, and mortality were more frequent for pa-
tients with than without renal injury (women, 20.6% vs 3.2%, P< .0001; men, 18.3% vs 2.2%, P< .001).
Renal injury was independently associated with 30-day mortality for women (odds ratio, 3.96; 95% confidence
interval, 1.86–8.44; P< .0001) and men (odds ratio, 4.05; 95% confidence interval, 2.19–7.48; P< .0001).
Conclusions: Postoperative renal injury is independently associated with 30-day mortality regardless of patient
sex. Higher rates of renal injury in women compared with men might be explained in part by a higher prevalence
of low estimated glomerular filtration rate before surgical intervention. (J Thorac Cardiovasc Surg
2010;140:1367-73)P
MWomen are at higher risk for mortality after cardiac surgery
than are men, but an explanation for this higher risk is not
completely clear.1 Understanding the sex-specific causes of
operative mortality is fundamental for developing preventa-
tive strategies. Acute renal failure develops in 5% to 30% of
patients after cardiac surgery when cardiopulmonary bypass
(CPB) is used, predisposing affected patients to in-hospital
and long-term mortality.2-6 Even small increases in serum
creatinine levels (0.5 mg/dL) after surgical intervention are
associated with high mortality, longer length of
hospitalization, and higher hospital costs.4,6 Female sex has
been identified as an independent risk factor for
postoperative renal failure, although it has not been
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The Journal of Thoracic and Carevaluated the role of postoperative renal dysfunction in
patient outcomes have not separately considered the effect
of female sex.2-6 This omission is important because
women represented a minority (<30%) of patients in these
studies, and the small number might limit extrapolation of
data derived predominately from men. Furthermore,
compared with men, women usually have less muscle mass
and are typically older at the time of surgical intervention;
both of these factors could affect the levels of serum
creatinine.1,8 Thus the purpose of this study was to evaluate
whether acute renal injury that develops after cardiac
surgery is more common in women than in men and
whether it is associated with operative mortality in women.MATERIALS AND METHODS
Study Design and Patient Population
All study procedures were approved by the institutional review board of
the Johns Hopkins Medical Institutions, and each patient provided written
informed consent for data collection and analysis before surgical interven-
tion. Data were prospectively collected by trained abstractors from an elec-
tronic medical records system at the Johns Hopkins Hospital as part of data
collection for the Society of Thoracic Surgeons (STS) National Cardiac Sur-
gery Database.9 Data collected included inpatient medical records, review
of outpatient records, letter mailings, and telephone interviews. Patients re-
ceiving preoperative dialysis were excluded from the study. We identified
9461 consecutive patients (30 years old) who had undergone coronarydiovascular Surgery c Volume 140, Number 6 1367
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
eGFR ¼ estimated glomerular filtration rate
RIFLE ¼ Risk, Injury, Failure, Loss, and End-Stage
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Martery bypass grafting (CABG) surgery, cardiac valve surgery, or both be-
tween January 1, 1995, and December 31, 2006. Patients’ serum creatinine
levels were obtained from a system-wide electronic patient record database.
Study End Points
Serum creatinine levels were measured as part of clinical care before and
after surgical intervention. The testing was carried out at the Clinical Chem-
istry Laboratory of the Johns Hopkins Hospital with commercial kits
(Roche Diagnostics, Indianapolis, Ind) that had a sensitivity of 0.2 mg/
dL (1995 to February 2003) or 0.1 mg/dL (February 2003 onward). The
last measurement before the day of surgical intervention was considered
the baseline value when more than 1 preoperative serum creatinine result
was available. In determining the change from baseline values, we consid-
ered the maximum serum creatinine level as the highest level obtained dur-
ing the first 7 days after surgical intervention. The estimated glomerular
filtration rate (eGFR) was estimated by using the Modification of Diet in
Renal Disease equations: eGFR ¼ 175 3 (Scr)1.154 3 (Age)0.203 in mil-
liliters per minute per 1.73 m2 of body surface area (the product was mul-
tiplied by 0.742 if the subject was female or by 1.212 if the subject was
African American).10,11
There is no universally accepted definition of renal injury after cardiac
surgery. We based our definition of renal injury on the Risk, Injury, Failure,
Loss, and End-Stage Kidney Disease (RIFLE) criteria: (1) risk when eGFR
decreases greater than 25% from baseline value; (2) injury when eGFR de-
creases greater than 50% from baseline value; and (3) failure when the
plasma creatinine level is 350 mmol/L or greater or when there is an acute
increase of 44 mmol/L or greater from the baseline value.12We also included
new dialysis as an indicator of renal failure. The primary renal outcome of
this study was the composite end point of renal injury or failure.
Statistical Analyses
Relevant clinical, demographic, and outcome variables from files in our
STS databases were extracted and merged into a STATA 10.0 data set,
which was used for all statistical analyses (StataCorp, College Station,
Tex). In initial confirmatory analyses we considered univariate tests of as-
sociations between operative mortality and renal injury on sex, clinical
measures, and complications from surgical intervention. These analyses
consisted of the c2 test for categorical variables and the Student’s t test
or, when appropriate, the nonparametric Kruskal–Wallis test for continu-
ous measures. Demographic and operative outcome variables with a P
value of less than .1 in univariate analyses or those that were deemed to
be clinically significant were considered in the multivariable logistic re-
gression model predicting renal injury and operative mortality. Here oper-
ative mortality was defined as death from any cause that occurred during
hospitalization or after discharge but within 30 days after surgical interven-
tion. We considered spline parameters to account for possible nonlinear as-
sociations for continuous variables on renal injury or operative mortality.
Definitions for clinical variables were those used by the STS database
found at http://www.sts.org/sections/stsnationaldatabase/datamanagers/
adultcardiacdb/datacollection/index.html.1368 The Journal of Thoracic and Cardiovascular SurRESULTS
Patient characteristics for the 9150 survivors and the 311
patients who experienced operative mortality are listed in
Table 1 according to patient sex. Operative mortality was
higher for women than for men (4.2% vs 3.0%,
P ¼ .001). Compared with survivors, women and men
who died were older and were more likely than surviving pa-
tients of the same sex to have low eGFRs before surgical in-
tervention. Other differences between survivors and
nonsurvivors for each sex are noted in Table 1. Comparisons
of the frequency of variables that differed between nonsur-
viving women and men are listed in Table 1. For the most
part, variables associated with mortality were similar be-
tween women and men, with a few exceptions. Compared
with nonsurviving men, women who experienced operative
mortality had a higher frequency of diabetes, left ventricular
ejection fraction of less than 50%, hypercholesterolemia,
hypertension, prior myocardial infarction, and current smok-
ing. Nonsurviving women had a lower frequency of triple-
vessel coronary artery disease than did nonsurviving men.
Differences in the type of operation between female and
male nonsurvivors were noted.
Baseline eGFR, the frequency of different levels of re-
duced eGFR, and the distribution of RIFLE criteria for renal
injury by patient sex are listed in Table 2. Women had
a lower eGFR before surgical intervention than did men,
and higher frequencies of women had eGFRs of less than
30 mL/min per 1.73 m2 of body surface area and eGFRs
of 30 to 60 mL/min per 1.73 m2 of body surface area.
Forty-four women and 33men were reported to have new di-
alysis after surgical intervention but were not listed as hav-
ing renal injury or failure based on the RIFLE criteria
(because of dialysis correction of serum creatinine levels);
these patients were included in the renal injury outcome.
The primary renal injury outcome occurred in 5.1% of
women and 3.6% of men (P< .001). The c2 value for
each category is provided in Table 2 and shows that most
of the weighting for the combined P value was from the RI-
FLE categories of ‘‘risk’’ or ‘‘injury,’’ suggesting that these
2 categories drive the statistical association between sex and
RIFLE criteria.
Characteristics for surviving and nonsurviving patients
with and without renal injury for each sex are listed in
Table 3. Although many univariate predictors of mortality
for patients with renal injury were similar for women and
men, differences were noted. As in Table 1, the frequency
of variables that differed between survivors and nonsurvivors
for each sex are listed, and comparisons between nonsurviv-
ing women and men are provided for these variables. In con-
trast to nonsurvivingmen, womenwith renal injury who died
had a higher frequency of left ventricular ejection fraction of
less than 30%, hypercholesterolemia, hypertension, triple-
vessel coronary artery disease, and significant left main cor-
onary stenosis. Nonsurviving women with renal injury hadgery c December 2010
TABLE 1. Patient characteristics of survivors and nonsurvivors based on patient sex
Clinical characteristic
Female
survivors
(n ¼ 2951)
Female
nonsurvivors
(n ¼ 129)
Frequency of
variable for
nonsurvivors
P
value*
Male
survivors
(n ¼ 6199)
Male
nonsurvivors
(n ¼ 182)
Frequency of
variable for
nonsurvivors
P
value*
P
valuey
Mean  SD age (y) 65.9  12.3 71.4  11.5 .0001 63.6  11.7 70.0  11.5 .0001 .8543
African American 492 (16.7%) 23 (17.8%) 4.5% .730 603 (9.7%) 17 (9.3%) 2.7% .862 .0117
Mean  SD body
surface area (m2)
1.80  0.23 1.77  0.23 .1365 2.05  0.22 1.97  0.24 .0001 .0001
Chronic lung disease 327 (11.1%) 16 (12.4%) 4.7% .640 532 (8.6%) 33 (18.1%) 5.8% .0001 .447
Diabetes 917 (31.1%) 49 (38.0%) 5.1% .098 1553 (25.0%) 53 (29.1%) 3.3% .213 .026
Left ventricular EF<50% 1489 (50.5%) 92 (71.3%) 5.8% .0001 3578 (57.7%) 123 (67.6%) 3.3% .008 .0001
Left ventricular EF<30% 334 (11.3%) 28 (21.7%) 7.7% .0001 856 (13.8%) 56 (30.8%) 6.1% .0001 .301
Reoperation 119 (4.0%) 13 (10.1%) 9.8% .001 165 (2.7%) 15 (8.2%) 8.3% .0001 .644
Hypercholesterolemia 1560 (52.9%) 61 (47.3%) 3.8% .214 3474 (56.0%) 75 (41.2%) 2.1% .0001 .001
Preoperative eGFR
<30 mL/min per 1.73m2 133 (4.5%) 17 (13.2%) 11.3% 144 (2.3%) 16 (8.8%) 10.0% .704
30-60 mL/min per 1.73 m2 708 (24.0%) 50 (38.8%) 6.6% .0001 971 (15.7%) 51 (28.0%) 5.0% .0001 .148
>60 mL/min per 1.73 m2 2110 (71.5%) 62 (48.1%) 2.9% 5084 (82.0%) 115 (63.2%) 2.2% .100
Hypertension 1997 (67.7%) 92 (71.3%) 4.4% .386 3982 (64.2%) 120 (65.9%) 2.9% .638 .002
IABP
Preoperative 47 (1.5%) 24 (18.6%) 10.1% 96 (1.5%) 29 (15.9%) 8.7% .636
Intraoperative 9 (0.3%) 6 (4.7%) 33.8% .0001 14 (0.2%) 4 (2.2%) 23.2% .0001 .108
Postoperative 124 (4.2%) 14 (10.9%) 40.0% 231 (3.7%) 22 (12.1%) 22.2% .448
MI 1194 (40.5%) 70 (54.3%) 5.5% .002 2849 (46.0%) 94 (51.6%) 3.2% .129 .0001
Emergency PCI 59 (1.9%) 1 (0.8%) 1.7% .340 111 (1.8%) 4 (2.2%) 3.5% .768 .662
Peripheral vascular disease 449 (15.2%) 25 (19.4%) 5.3% .212 740 (11.9%) 39 (21.4%) 5.0% .0001 .835
Cerebral vascular disease 381 (12.9%) 23 (17.8%) 5.7% .110 599 (9.7%) 34 (18.7%) 5.4% .0001 .825
Cardiac shock 17 (0.6%) 4 (3.1%) 19.0% .010 39 (0.6%) 4 (2.2%) 9.3% .033 .422
Current smoking 380 (12.9%) 15 (11.6%) 3.8% .788 827 (13.3%) 15 (8.2%) 1.8% .045 .032
Triple-vessel CAD 1253 (42.5%) 59 (45.8%) 4.5% .659 3531 (57.0%) 87 (47.8%) 2.4% .118 .0001
Left main
stenosis>50%
259 (8.8%) 14 (10.8% 5.1% .525 607 (9.8%) 17 (9.3%) 2.7% .895 .070
Type of operation
CABG only
With CPB 1984 (67.2%) 90 (69.8%) 4.4% .833 4808 (77.6%) 132 (72.5%) 2.7% .144 .0001
Without CPB 96 (3.3%) 4 (3.1%) 4.0% 214 (3.4%) 5 (2.7%) 2.3% .469
AVR
Repair 120 (4.%1) 3 (2.3%) 2.4% .046 304 (4.9%) 7 (3.8%) 2% .001 1.00
Replacement 588 (19.9%) 37 (28.7%) 5.9% 981 (15.8%) 48 (26.4%) 4.7% .262
MVR
Repair 151 (5.1%) 5 (3.9%) 3.2% .705 256 (4.1%) 8 (4.4%) 3.0% .002 1.00
Replacement 486 (16.5%) 24 (18.6%) 4.7% 357 (5.8%) 22 (12.1%) 5.8% .464
CABG/AVR 247 (8.4) 12 (9.3%) 8.5% .0001 482 (7.8%) 27 (14.8%) 5.3% .001 .082
CABG/MVR 175 (5.9%) 9 (7.0%) 4.9% .645 210 (3.4%) 16 (8.8%) 7.1% .0001 .357
Duration of aortic
crossclamp (min)z
72 (55–96) 81 (60–111) .0331 75 (58–98) 83 (56–124) .0334 .692
Duration of CPB (min)z 109 (86–139) 139 (99–173) .0001 111 (89–138) 136 (100–189) .0001 .974
Values are reported as number of patients, with percentages in parentheses for the variable for each column of survivor or nonsurvivors. A separate column of percentages lists the
frequency of the variable for nonsurvivors for each sex. SD, Standard deviation; EF, ejection fraction; eGFR, estimated glomerular filtration rate; IABP, intra-aortic balloon pump;
MI, myocardial infarction; PCI, percutaneous coronary artery intervention;CAD, coronary artery disease;CABG, coronary artery bypass graft;CPB, cardiopulmonary bypass; AVR,
aortic valve replacement;MVR, mitral valve replacement. *P value for comparison between survivors and nonsurvivors of the same sex. yP value for comparison of the distribution
of the variable between women and men. zValues are reported as medians (interquartile ranges).
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Ma lower frequency of left ventricular ejection fraction of less
than 50% than did nonsurviving men with renal injury.
Perioperative complications and operative mortality are
listed in Table 4 based on the presence or absence of renal
injury for both sexes. With the exception of perioperativeThe Journal of Thoracic and Carmyocardial infarction, reported complications were more
common in patients with renal injury than in those without
such injury, irrespective of sex. In addition, duration of me-
chanical lung ventilation and duration of intensive care unit
hospitalization were longer in patients of both sexes withdiovascular Surgery c Volume 140, Number 6 1369
TABLE 2. eGFR (in milliliters per minute per 1.73 m2) and the
number and percentage of patients with different levels of decreased
eGFR and each RIFLE criterion based on patient sex
Parameter Women Men
c2
test
P
value
Baseline eGFR* 75.3 (57.1–101.5) 81.6 (65.3–101.0) NA .0001
eGFR<30 154 (5.0%) 162 (2.5%) .0001
eGFR 30–60 772 (25%) 1039 (16.3%)
No renal injury 2918 (94.7%) 6119 (95.9%) 0.3
RIFLE risk 50 (1.6%) 62 (1.0%) 7.5 .001
RIFLE injury 27 (0.9%) 25 (0.4%) 8.9
RIFLE failure 85 (2.8%) 175 (2.7%) 0.0
The c2 value for each RIFLE category is provided to indicate the relative weighting of
each category for the combined P value. eGFR, Estimated glomerular filtration rate;
NA, not applicable. RIFLE, Risk, Injury, Failure, Loss, and End-Stage Kidney Disease.
*Median (interquartile range). RIFLE criteria: risk, eGFR decrease greater than 25%
from baseline; injury, eGFR decrease greater than 50% from baseline; and failure,
acute plasma creatinine level of 350 mmol/L or greater or acute increase of 44 mmol/L
or greater after surgical intervention.
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Mrenal injury compared with durations in those without this
complication. Operative mortality was markedly higher in
both women and men with renal injury than in patients
who did not have renal injury.
Variables independently associated with renal injury are
listed in Table 5. Factors independently associated with renal
injury after correction for baseline eGFR are listed in Table
6. Whereas male sex was independently associated with
a reduced risk of renal injury in the first model, after correc-
tion for baseline eGFR in the second model, patient sex was
no longer significantly related to the risk for renal injury. Be-
cause of the nonlinear relationship between eGFR and risk
for renal injury, these data were splined at a baseline eGFR
of 100mL/min per 1.73m2 of body surface area. AU-shaped
relationship between baseline eGFR and risk for renal injury
was observed; that is, a reduced risk for renal injury was as-
sociated with a baseline eGFR of 100 mL/min per 1.73 m2.
The risk of renal injury was higher above and below a base-
line eGFR of 100 mL/min per 1.73 m2.
Independent predictors of operative mortality based on
multivariate logistic regression analysis in a model that in-
cluded both women and men are listed in Table 7. Multior-
gan failure was a strong predictor for operative mortality.
Renal injury was associated with risk for operative mortality
for women and men after adjustment for other variables as-
sociated with death.DISCUSSION
The data presented here show that the frequency of renal
injury is more common in women than in men after cardiac
surgery. This risk, however, might be explained in part by
women having a lower baseline eGFR thanmen. In our study
patients with renal injury generally had more predisposing
risk factors for morbidity and were more likely to have post-
operative complications thanwere those who did not have re-1370 The Journal of Thoracic and Cardiovascular Surnal injury, regardless of sex. Renal injury was independently
associated with operative mortality for women and men.
Women have consistently been shown to have higher op-
erative mortality after cardiac surgery than men due in part to
a higher prevalence of risk factors for poor outcomes,
including advanced age.1,13-15 Nonetheless, in the large
multicenter STS database, female sex was reported to be
an independent predictor of operative mortality for all but
the highest-risk patients.1 Our group has reported that a large
portion of the excessive risk for operative mortality in
women can be explained by a higher prevalence of perioper-
ative stroke in women than in men.13,14 The results of the
current study now show that renal injury is an additional
important determinant for operative mortality in women
after cardiac surgery.
Renal insufficiency and renal failure after cardiac surgery
are known to be associated with risk for adverse operative out-
comes, including in-hospital, short-term, and long-term mor-
tality.2-6 Prior studies have reported that women are at higher
risk for renal injury after cardiac surgery, but these findings
are inconsistent.2,7,16 One explanation for why women might
have increased susceptibility to postoperative renal injury is
that they have a higher prevalence of predisposing risk
factors compared with men, including advanced age,
diabetes, and hypertension.1,2,13,15 Another explanation
might be related to the modulating effects of sex hormones
on renal physiology and responses to ischemia and
reperfusion.17 Studies in whole-animal models have demon-
strated greater functional and histologic injury from global re-
nal ischemia inmale than in female animals, a finding linked to
male and female sex steroids.17 Whether the absence of estro-
gens associated with the postmenopausal state modifies these
responses is not entirely clear. Nonetheless, in our study we
found that after correcting for baseline eGFR, patient
sex was no longer significantly associated with renal injury af-
ter surgical intervention. Because we found that women had
lower eGFRs before surgical intervention than did men, our
findings indicate that the higher risk of postoperative renal in-
jury in women is related in part to their lower baseline eGFRs
that might, perhaps, contribute to less functional reserve to
injury.
Previous investigations that have examined the impor-
tance of renal injury on patient outcomes after cardiac sur-
gery have not separately examined whether this risk
applies equally to women and men. Rather, most studies
have combined data from both sexes, a design that might
limit extrapolation of the data to women because they are
a minority of cardiac surgical patients.2-6 Another
disadvantage of the previous studies that might limit
comparisons is that they have used multiple definitions for
renal injury based on changes in serum creatinine levels.3
Serum creatinine levels are influenced by multiple factors
in addition to glomerular filtration.8 Thus relative, absolute,
or both serum creatinine concentrations might poorly predictgery c December 2010
TABLE 3. Distribution of risk factors for operative mortality for patients with and without renal injury based on patient sex
Clinical characteristic
Women, no
renal injury
(n ¼ 2959)
Women,
renal injury
(n ¼ 160)
Frequency of
variable for
nonsurvivors
P
value*
Men, no
renal injury
(n ¼ 6230)
Men,
renal injury
(n ¼ 235)
Frequency of
variable for
nonsurvivors
P
value*
P
valuey
Mean  SD age (y) 66.2  12.3 66.6  12.5 .688 63.7  11.7 65.9  12.9 .006 .7120
African American race 488 (16.5%) 39 (24.4%) 7.4% .010 603 (9.7%) 17 (9.3%) 7.3% <.0001 .967
Mean  SD BSA (m2) 1.8  0.2 1.8  0.2 .148 2.0  0.2 2.0  0.2 2.0  0.2 .687 .687
Chronic lung disease 327 (11.0%) 20 (12.5%) 5.8% .570 532 (8.6%) 33 (18.1%) 6.0% .002 .885
Diabetes 921 (31.1%) 58 (36.2%) 5.9% .174 1553 (25.0%) 53 (29.1%) 4.6% .015 .141
Left ventricular EF<50% 1501 (50.7%) 98 (61.2%) 6.12% .009 3578 (57.7%) 123 (67.6%) 13.7% .582 <.0001
Left ventricular EF<30% 333 (11.2%) 33 (20.6%) 9.06% <.001 856 (13.8%) 56 (30.8%) 5.0% .018 .006
Reoperation 114 (3.8%) 19 (11.9%) 14.3% <.001 165 (2.7%) 15 (8.2%) 8.6% <.0001 .106
Hypercholesterolemia 1567 (53.0%) 77 (48.1%) 4.7% .233 3474 (56.0%) 75 (41.2%) 2.9% <.0001 .001
Hypertension 1995 (67.4%) 122 (76.2%) 5.8% .020 3991 (64.1%) 167 (71.1%) 4.0% .028 .002
IABP
Preoperative 125 (4.2%) 13 (8.1%) 9.4% .017 228 (3.7%) 25 (10.6%) 9.9% .116 .883
Intraoperative 59 (2.0%) 13 (8.1%) 18.1% 17 (0.3%) 1 (0.4%) 5.6% .784
Postoperative 10 (0.3%) 5 (3.1%) 33.3% 106 (45.1%) 21 (8.9%) 3.3% .784
Myocardial infarction 1217 (41.1%) 60 (37.5%) 4.7% .363 2849 (46.0%) 94 (51.6%) 3.3% .232 .032
Emergency PCI 58 (2.0%) 2 (1.0%) 3.3% .320 111 (1.8%) 4 (2.2%) 1.7% .372 .608
PVD 448 (15.1%) 29 (1.8%) 6.1% .307 740 (11.9%) 39 (21.4%) 5.0% .032 .402
Cerebral vascular disease 381 (12.9%) 25 (15.6%) 6.2% .314 599 (9.7%) 34 (18.7%) 4.4% .284 .204
Cardiogenic shock 22 (0.7%) 1 (0.6%) 4.3% .865 39 (0.6%) 4 (2.2%) 13.6% .408
Current smoker 383 (12.9%) 16 (10.0%) 4.0% .278 827 (13.3%) 15 (8.2%) 3.5% .668
Triple-vessel disease 1271 (42.9%) 52 (32.5%) 3.9% .274 3531 (57.0%) 87 (47.8%) 2.7% .030
Left main
stenosis>50%
261 (8.8%) 14 (8.7%) 5.1% .524 607 (9.8%) 17 (9.3%) 2.2% .022
Type of operation
CABG only .003
With CPB 1991 (67.3%) 86 (53.7%) 4.1% <.0001 4808 (77.6%) 132 (72.5%) 2.9% <.0001 .008
Without CPB 93 (3.1%) 7 (4.4%) 7.0% 214 (3.4%) 5 (2.7%) 5.9%
AVR
Repair 120 (4.0%) 3 (1.9%) 2.4% <.0001 304 (4.9%) 7 (3.8%) 6.1% <.0001 .804
Replacement 573 (19.4%) 53 (33.1%) 8.5% 981 (15.8%) 48 (26.4%) 6.0%
MVR
Repair 147 (5.0%) 9 (5.6%) 5.8% .004 256 (4.1%) 8 (4.4%) 3.0% <.0001 .147
Replacement 462 (15.6%) 49 (30.6%) 9.6% <.0001 357 (5.8%) 22 (12.1%) 8.7%
CABG/AVR 247 (8.3%) 24 (15.0%) 8.9% 482 (7.8%) 27 (14.8%) 7.4% <.001 .057
CABG/MVR 164 (5.5%) 20 (12.5%) 21.9% 210 (3.4%) 16 (8.8%) 4.9% .345 .169
Duration aortic
crossclamp (min)z
72 (55–96) 85 (62–113) .0005 75 (58–97) 86 (59–118) <.0001 .816
Duration of CPB (min)z 109 (86–139) 138 (104–177) .0001 111 (89–138) 129 (100–186) .0001 .461
Values are reported as numbers of patients, with percentages in parentheses for the variable for each column of survivors or nonsurvivors. A separate column of percentages lists the
frequency of the variable for patients without renal injury for each sex. SD, Standard deviation; BSA, body surface area; EF, ejection fraction; IABP, intra-aortic balloon pump; PCI,
percutaneous coronary artery intervention; PVD, peripheral vascular disease; CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; AVR, aortic valve replacement;
MVR, mitral valve replacement. *P value for comparison between survivors and nonsurvivors of the same sex. yP value for comparison of the distribution of the variable between
women and men. zValues are reported as medians (interquartile ranges).
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Mrenal function in elderly women. In this study we estimated
eGFR with the Modification of Diet in Renal Disease equa-
tions, which take into account age, sex, and race.10,11
Furthermore, we used RIFLE criteria for defining grades
of renal injury.12 Regardless, the frequency of renal injury
and the associated mortality in our study were similar to
those of other studies.2-6,18-20
Renal injury associated with cardiac surgery likely results
from hypotension, embolism, or exposure to nephrotoxins,
including radiocontrast dye used before surgical interven-The Journal of Thoracic and Cartion.4,21,22 Patients with renal injury are more likely than
others to have postoperative complications. The development
of complications, such as sepsis and other organ injury,
might predispose them to hemodynamic instability and renal
ischemia, as well as to exposure to nephrotoxic antibiotics.
Nonsurgical patients with renal injury have prothrombotic
tendency, endothelial dysfunction, and other abnormalities
that predispose them to cardiovascular disease.23 Perhaps these
variables contribute to the poorer outcomes seen in patients
with renal injury after cardiac surgery. In our study wediovascular Surgery c Volume 140, Number 6 1371
TABLE 4. Variables independently associated with renal injury based
on multivariate logistic regression analysis
Variable Odds ratio (95% CI) P value
Multiorgan failure 14.44 (8.57–24.33) .0001
African American race 1.83 (1.39–2.42) .0001
Duration of cardiopulmonary
bypass
1.01 (1.01–1.02) .0001
Male sex 0.68 (0.54–0.85) .001
Hypertension 1.50 (1.17–1.93) .002
Left ventricular
ejection fraction<30%
1.48 (1.11–1.96) .007
Hypercholesterolemia 0.77 (0.61–0.96) .021
CI, Confidence interval.
TABLE 5. Variables independently associated with renal injury
Variable Odds ratio (95% CI) P value
Multiorgan failure 12.65 (7.00–22.87) .0001
African American race 1.80 (1.32–2.44) .0001
Duration of cardiopulmonary
bypass
1.01 (1.005–1.01) .0001
Baseline eGFR<100 mL/min
per 1.73 m2*
0.94 (0.94–0.95) .0001
Baseline eGFR 100 mL/min
per 1.73 m2y
1.08 (1.07–1.10) .0001
Calculations are based on multivariate logistic regression analysis after adjusting for
baseline estimated glomerular filtration rate with a linear spline at 100 mL/min per
1.73 m2. CI, Confidence interval; eGFR, estimated glomerular filtration rate. *The
risk for each 1-unit increase in eGFR when baseline eGFR is less than 100 mL/min
per 1.73 m2 of body surface area. yThe risk for a 1-unit increase in eGFRwhen baseline
eGFR is greater than 100 mL/min per 1.73 m2 of body surface area.
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Mobserved an apparent U-shaped relationship between baseline
eGFR values and risk for renal injury after surgical interven-
tion. At less than a baseline of 100 mL/min per 1.73 m2 of
body surface area, each unit increase in eGFR reduced the
risk for renal injury. In contrast, for patients with baseline
eGFRs of greater than100mL/minper 1.73m2 of body surface
area, each unit increase in eGFR increased the risk for renal in-
jury. Reasons for the latter observation are not clear other than
the potential forhigher renal embolic loadduring surgical inter-
vention for patients with high baseline eGFRs. Importantly,
our observations suggest that optimizing the eGFR before
surgical intervention in patients with a baseline eGFR of up
to 100mL/min per 1.73m2 of body surface areamight provide
a strategy for reducing the risk for renal injury, particularly in
women. One potential strategy would be to allow recovery
of renal function from radiocontrast dye exposure before
subjecting patients to the added risk of renal injury for surgical
perturbations.
Many of the variables that we identified to be indepen-
dently associated with mortality are widely recognized.1
Women are likely to be older than men at the time of surgical
intervention and are more likely to have hypertension, fewer
coronary artery stenoses, and preserved left ventricular func-
tion.1 Thus differences in preoperative comorbidities be-
tween patient sexes might confound our examination ofTABLE 6. Postoperative complications and outcomes
Women
Clinical characteristic
No renal
injury (n ¼ 2920)
Renal
Injury (n ¼ 160)
Reoperation for bleeding 41 (1.4%) 9 (5.6%)
Stroke 158 (5.3%) 23 (14.4%)
Perioperative MI 10 (0.3%) 0
Pneumonia 77 (2.6%) 12 (7.5%)
Sepsis 43 (1.4%) 28 (17.5%)
Multiorgan failure 17 (0.6%) 10 (6.2%)
Duration in the ICU (h) 48 (24–96) 191 (84–456)
Duration of lung
ventilation (h)
13 (9–22) 110 (30–268)
Operative mortality 96 (3.2%) 33 (20.6%)
MI, Myocardial infarction; ICU, intensive care unit.
1372 The Journal of Thoracic and Cardiovascular Surthe importance of renal injury for operative mortality. None-
theless, most of these risk factors for mortality were similar
between patient sexes based on univariate analysis, although
several variables did differ between survivors and nonsurvi-
vors in analysis within each sex. However, our use of multi-
variate logistic regression analysis to adjust for other
potential confounding factors between the sexes suggests
that a higher comorbidity rate in women with renal injury
is an unlikely explanation for the link between this outcome
and operative mortality. We observed that hypercholesterol-
emia was associated with lower mortality risk in men. This
finding might represent an epiphenomenon that identifies
patients receiving statin drugs, which have been shown to
be associated with a decreased risk for mortality after cardiac
surgery.24 However, whether preoperative statin therapy de-
creases the risk of postoperative acute kidney injury is not
conclusive.24,25
In addition to the retrospective nature of this analysis, sev-
eral limitations are associated with this study. Our analysis
included a heterogeneous population of patients undergoing
CABG surgery, valvular surgery, or both. Serum creatinine
levels, which were used in the definition of renal injury,
might have been influenced by nonrenal factors, includingMen
P value
No renal
Injury (n ¼ 6146)
Renal
Injury (n ¼ 235) P value
<.0001 91 (1.5%) 17 (7.2%) <.0001
<.0001 212 (3.4%) 24 (10.2%) <.0001
.453 19 (0.3%) 2 (0.8%) .160
<.0001 170 (2.7%) 29 (12.3%) <.0001
<.0001 72 (1.1%) 38 (16.2%) <.0001
<.0001 28 (0.4%) 25 (11.9%) <.0001
.0001 36 (22–69) 165 (73–449) .0001
.0001 10 (7–16) 63 (14–281) <.0001
<.0001 139 (2.2%) 43 (18.3%) <.0001
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TABLE 7. Variables independently associated with mortality after
cardiac surgery based on multivariate logistic regression analysis
Variable Odds ratio (95% CI) P value
Multiorgan failure 31.57 (16.23–63.39) .0001
Reoperation for bleeding 3.98 (2.22–7.13) .0001
Male subject with renal injury 3.72 (2.21–6.23) .0001
Female subjects with renal injury 3.77 (2.18–6.54) .0001
Stroke 3.60 (2.49–5.22) .0001
Left ventricular ejection fraction<30% 2.05 (1.50–2.82) .0001
Duration of cardiopulmonary bypass 1.01 (1.01–1.02) .0001
Duration of aortic crossclamping 0.99 (0.98–0.99) .0001
Hypercholesterolemia 0.75 (0.57–0.94) .042
CI, Confidence interval.
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P
Mbody weight, ethnicity, sex, and nutrition.1,8 Cystatin C is an
endogenous marker of renal function that is more sensitive
than creatinine for identifying mild and moderate
decrements in eGFR.26 Although use of the latter marker
might have provided a more accurate detection of mild renal
injury, it was not widely available or routinely measured
during the period of this study. Likewise, aprotinin use, a var-
iable found in retrospective studies to be associated with
renal injury, was not recorded in our database.27 Antifibrino-
lytic drugs consisted of aminocaproic acid; aprotinin was
mostly restricted to reoperative surgery. Whether inclusion
of aprotonin in our multivariate models of operative mortal-
ity would have modified our finding that renal injury is inde-
pendently associated with operative mortality in women and
men is not known but unlikely because only a minority of
patients received the drug.
In summary, we have shown that the occurrence of renal
injury after cardiac surgery is independently associated with
an increased risk of postoperative mortality. Furthermore,
the incidence of renal injury after cardiac surgery appears
to be higher in women than in men. However, this discrep-
ancy could be caused in part by women having a lower base-
line eGFR than men. Optimizing eGFR before surgical
intervention in patients with a baseline eGFR of less than
100 mL/min per 1.73 m2 of body surface area and allowing
patients time to recover renal function after exposure to renal
toxins, such as radiocontrast dye, might provide strategies
for reducing the risk of renal injury after cardiac surgery.References
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